Gitnux/Report 2026

Pathology Industry Statistics

The global pathology services market is estimated at $36.14 billion in 2026, explore the figures behind growth, company scale, and key operating constraints.
28Statistics
29Sources
5Sections
1Visuals
16mRead
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 37 days

01 Industry overview

The pathology industry at a glance

The global pathology services market is estimated at $36.14 billion in 2026, with growth driven by molecular testing, precision medicine, digital pathology and AI-assisted diagnostic workflows.

$36.14B[3]
Global market size, 2026
7.2%[3]
Forecast CAGR, 2026–2030
313,700[8]
U.S. laboratory jobs, 2025
$11.04B[12]
Quest revenue, 2025
Market size
The global pathology services market was valued at $33.78 billion in 2025 and is estimated at $36.14 billion in 2026. A separate pathology-laboratories estimate places the market at $386.2 billion in 2024, reflecting a broader market definition that includes laboratory testing beyond pathology services.[3][1]
Forecast & CAGR
The pathology services market is forecast to reach $47.79 billion by 2030, representing a 7.2% CAGR from 2026 to 2030. The broader pathology-laboratories market is projected to grow at an 8.1% CAGR from 2025 to 2030.[3][1]
Market share & regions
North America was the largest regional market in 2025, while Asia-Pacific is expected to be the fastest-growing region through 2030. Available regional reporting covers North America, South America, Europe, Asia-Pacific, the Middle East and Africa.[3]
Segmentation
Pathology laboratories are commonly segmented by facility type, including hospital-based and standalone laboratories, and by testing services such as general physiological and clinical tests and COVID-19 testing. End-use segmentation includes physician referrals and other healthcare settings.[1]
Key players & concentration
Major providers include Labcorp, Quest Diagnostics, Eurofins Scientific, Sonic Healthcare, SYNLAB, Unilabs and Mayo Clinic Laboratories. Quest Diagnostics reported $11.04 billion in 2025 revenue, served half of U.S. physicians and hospitals, and employed nearly 57,000 people, illustrating the scale of leading reference laboratories.[12][3]
Pricing
U.S. Medicare prices most clinical diagnostic laboratory tests using the weighted median of private-payer rates under the Clinical Laboratory Fee Schedule. CMS stated that the payment-reduction cap was 0% for 2026, while the 2026 CLFS file contained 2,243 records in its fourth-quarter release.[4]
Trends, drivers & challenges
Growth is being supported by AI-enabled diagnostic interpretation, digital pathology, precision medicine, molecular testing, cloud-based pathology platforms and preventive screening. Staffing remains a constraint: the 2024 ASCP vacancy survey reported elevated vacancies across several pathology and laboratory departments, while U.S. medical and diagnostic laboratory employment was 313,700 in December 2025.[3][10][8]
Consumer behavior & competition
Demand is largely physician-directed and includes routine preventive testing, chronic-disease monitoring, cancer diagnostics, genetic testing and advanced genomic services. Quest Diagnostics reports serving one in three U.S. adults each year, indicating strong consumer reach among national reference laboratories.[12][1]
M&A
Consolidation continued in 2025 and 2026. Reported transactions included Labcorp’s acquisition of selected BioReference Health oncology and clinical-testing assets in March 2025, Quest Diagnostics’ acquisition of selected Spectra Laboratories assets in February 2025, and Tempus AI’s $600 million acquisition of Ambry Genetics in February 2025.[13][14]
Regulation
U.S. laboratories operate under CLIA requirements and Medicare payment rules administered through the Clinical Laboratory Fee Schedule. CMS issued the 2026 annual CLFS update effective January 1, 2026, and its October 2026 update added or revised HCPCS and CLIA-related coding provisions.[4]
Latest news
The most recent industry developments include continued reference-laboratory consolidation, expansion of oncology and genomic testing portfolios, and further adoption of digital pathology and AI. In March 2026, Labcorp acquired 12 patient service centers from Lab Alliance of CNY and agreed to manage Crouse Health’s inpatient laboratory operations.[14][3]

02 Ranking

Top 10 Companies in the Pathology Industry

The leading companies in the pathology industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 22, 2026 · Next review December 22, 2026

Verdict

Roche stands out for in-vitro diagnostics and digital pathology because it reported CHF 13.8 billion in 2025 Diagnostics sales, while Siemens Healthineers leads in laboratory systems since it reported €4.347 billion in Diagnostics revenue for fiscal 2025.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in in-vitro diagnostics & digital pathology

    Roche

    CH

    Ranked #1 · 9.5 · In-vitro diagnostics & digital pathology

    Why we picked it: Its in-vitro diagnostics and digital pathology business supports pathology workflow adoption through measured scale.

  2. Leader in reference pathology services

    Labcorp

    US

    Ranked #3 · 9.1 · Reference pathology services

    Why we picked it: Its clinical and anatomic pathology laboratory services show reference-lab volume across global networks.

  3. Leader in pathology reagents & lab systems

    Thermo Fisher Scientific

    US

    Ranked #5 · 8.9 · Pathology reagents & lab systems

    Why we picked it: Its specialty diagnostics and pathology reagents support automation and provisioning of lab testing capacity.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the pathology industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Roche

In-vitro diagnostics & digital pathology · CH

9.5
2

Siemens Healthineers

In-vitro diagnostics & digital pathology · DE

9.3
3

Labcorp

Reference pathology services · US

9.1
4

Quest Diagnostics

Reference pathology services · US

8.9
5

Thermo Fisher Scientific

Pathology reagents & lab systems · US

8.9
6

Eurofins Scientific

Clinical diagnostics and pathology testing services · LU

8.8
7

Sakura Finetek

Histology instruments, reagents and automation · JP

8.6
8

Unilabs

Clinical laboratory, pathology and genetics services · CH

8.4
9

Danaher

Anatomic pathology, laboratory diagnostics and molecular testing · US

8.4
10

NeoGenomics

Oncology pathology and molecular diagnostics · US

8.1

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 22, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 22). Top 10 companies in the pathology industry. In Pathology Industry Statistics. Gitnux. https://gitnux.org/pathology-industry-statistics/#top-companies

report visual · Comparison

Revenue of the largest pathology companies

Roche leads with $69.5B in annual revenue (group level, converted to USD).

Roche$69.5B
Thermo Fisher Scientific$44.6B
Siemens Healthineers$25.2B
Danaher$24.6B
Labcorp$14.0B
Quest Diagnostics$11.0B
source-verifiedroche.com · sec.gov · siemens-healthineers.com · labcorp.com · newsroom.questdiagnostics.com2025

04 Statistics

Market Intelligence

We track how definitions shift between pathology laboratories and pathology services, including $36.14 billion for 2026 pathology services and $386.2 billion for 2024 laboratories.

Market size and service revenue in the pathology industry

  • $386.2 billion was the estimated 2024 global pathology laboratories market, covering hospital-based and standalone laboratories and testing services.[1]
  • $212.8 billion was the estimated 2024 global pathology services market, covering pathology services including biopsy analysis, tumor profiling, companion diagnostics, digital pathology and molecular testing.[2]
  • $36.14 billion was the estimated 2026 global pathology services market, covering laboratory testing, diagnostic analysis, specimen collection, histopathology and consultation services, including related consumables.[3]

Growth forecasts for the pathology industry

  • The global pathology laboratories market is projected to reach $612.2 billion by 2030 from $386.2 billion in 2024, at an 8.1% CAGR during 2025–2030.[1]
  • The global pathology services market is projected to grow from $212.8 billion in 2024 to $307.9 billion by 2030, representing a 6.5% CAGR during 2025–2030.[2]
  • The global pathology services market is projected to reach $47.79 billion by 2030, growing at a 7.2% CAGR from 2026 to 2030; the study covers clinical, anatomical, molecular, cytopathology and forensic pathology services.[3]

Firm counts and size structure in the pathology industry

  • 7,802 U.S. independent laboratories were registered under CLIA in November 2026, representing 2.62% of all registered laboratories.[4]
  • 15,151 U.S. compliance laboratories were distributed across annual test-volume bands in November 2026; 5,894 handled 2,000 or fewer tests and 199 handled more than 1 million tests.[4]
  • 297,756 U.S. laboratories were registered under CLIA in November 2026, including exempt and non-exempt laboratories; 115,351 were physician-office laboratories.[4]
  • 230,652 U.S. non-exempt laboratories held CLIA waiver certificates in November 2026, representing the largest certificate category.[4]

Regional breakdown of the pathology industry

  • 26,323 laboratories were registered in Florida under CLIA in November 2026, comprising 1,273 compliance, 22,330 waiver, 708 microscopy and 1,312 accreditation laboratories.[4]
  • 29,945 laboratories were registered in Texas under CLIA in November 2026, comprising 934 compliance, 23,968 waiver, 1,624 microscopy and 2,488 accreditation laboratories.[4]
  • 22,805 laboratories were registered in California under CLIA in November 2026, comprising 1,424 compliance, 18,208 waiver, 1,897 microscopy and 1,215 accreditation laboratories.[4]

05 Statistics

Strategy & Growth

We focus on consolidation signals with deal counts and total value, including 34 clinical laboratory services M&A deals in Q3 year-to-date 2025.

M&A and consolidation in the pathology industry

  • 34 clinical laboratory services M&A deals were recorded in Q3 year-to-date 2025, up from 30 in Q3 year-to-date 2024; the study covers clinical laboratory services, including pathology, globally.[5]
  • US$0.1 billion was the aggregate clinical laboratory services M&A deal value in Q3 year-to-date 2025, down from US$0.8 billion in Q3 year-to-date 2024; scope includes pathology within clinical laboratory services.[5]
  • More than 15 acquisitions were completed by Quest Diagnostics and Labcorp combined from Q1 2024 through June 2025, evidencing continued consolidation among US and Canadian laboratory and diagnostic services providers, including pathology.[6]

06 Statistics

People & Workforce

We isolate capacity constraints using employment and practitioner counts, including 313,700 U.S. laboratory jobs in 2025 and 21,244 active pathologists in 2023.

Employment and hiring in the pathology industry

  • 21,244 active pathologists were reported in the United States in 2023; this is a pathology-practitioner capacity and employment count.[7]
  • 2,180 physicians, pathologists were employed in California in May 2024, the largest state employment count shown by BLS for this occupation.[8]
  • 1,100 physicians, pathologists were employed in Texas in May 2024, according to BLS occupational employment estimates.[8]
  • 940 physicians, pathologists were employed in New York in May 2024, according to BLS occupational employment estimates.[8]

07 Statistics

Risk & Compliance

We summarize CLIA certificate fees and timing, including the $297 biennial fee for provider-performed microscopy and the 2-year validity period for all CLIA certificate types.

Regulation and licensing in the pathology industry

  • $297 is the biennial CLIA certificate fee for U.S. laboratories performing provider-performed microscopy, effective January 27, 2024.[4]
  • $248 is the biennial CLIA certificate fee for U.S. laboratories holding a Certificate of Waiver, effective January 27, 2024.[4]
  • $11,801 is the biennial CLIA certificate fee for laboratories processing more than 1,000,000 tests annually, effective January 27, 2024.[4]
  • 2 years is the validity period for all CLIA certificate types in the United States, under CMS laboratory-certification requirements currently in force.[4]
  • $223 is the biennial CLIA certificate fee for low-volume laboratories processing 2,000 or fewer tests annually, effective January 27, 2024.[4]

08 Statistics

Sustainability

We compile pathology-scope sustainability measurements and survey adoption, including 117 tCO₂e for a surgical pathology laboratory in Lille in 2021.

Energy, emissions and disclosure in the pathology industry

  • 0.5% of Saint Vincent Hospital’s total emissions came from its surgical pathology laboratory in 2021; no newer whole-laboratory measurement was identified.[9]
  • 117 tCO₂e was the 2021 carbon footprint of a surgical pathology laboratory in Lille, France, covering 17,242 patient cases and 54,124 paraffin blocks; no newer whole-laboratory measurement was identified.[10]
  • 18 of 27 European pathology-society respondents reported institutional sustainability efforts at laboratory level in 2026, representing 67% of respondents.[11]

Key questions about the pathology industry

What is the global pathology services market size in 2026?
The global pathology services market is estimated at $36.14 billion in 2026.
How fast does the pathology services market grow through 2030?
The market is forecast to reach $47.79 billion by 2030, representing a 7.2% CAGR from 2026 to 2030.
Which companies lead the pathology industry?
Roche stands out for in-vitro diagnostics and digital pathology because it reported CHF 13.8 billion in 2025 Diagnostics sales, while Siemens Healthineers leads in laboratory systems since it reported €4.347 billion in Diagnostics revenue for fiscal 2025.
Which technology shifts are most cited in pathology services?
Growth is supported by digital pathology, AI-enabled diagnostic interpretation, and molecular testing, alongside cloud-based pathology platforms.
How is the U.S. pathology laboratory market structured by compliance and test volume?
In November 2026, 230,652 U.S. non-exempt laboratories held CLIA waiver certificates, while 15,151 compliance laboratories were distributed across annual test-volume bands.
What regulatory and pricing mechanics affect U.S. lab economics in 2026?
U.S. laboratories operate under CLIA and Medicare payment rules under the Clinical Laboratory Fee Schedule; CMS set a 0% payment-reduction cap for 2026 and issued the annual CLFS update effective January 1, 2026.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 22). Pathology Industry Statistics. Gitnux. https://gitnux.org/pathology-industry-statistics
MLA
Samuel Norberg. "Pathology Industry Statistics." Gitnux, 22 Nov 2026, https://gitnux.org/pathology-industry-statistics.
Chicago
Samuel Norberg. 2026. "Pathology Industry Statistics." Gitnux. https://gitnux.org/pathology-industry-statistics.